Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

As Hurricane Milton approaches the Gulf Coast, the American Lung Association has released critical health guidance for ...

Hope is on the horizon for patients living with chronic obstructive pulmonary disease (COPD). CHEST 2024 in Boston featured a session highlighting emerging bronchoscopic therapies.

COIMBATORE: A total of 1,039 people have been diagnosed with early Chronic Kidney Diseases (CKD) in Coimbatore district ...

Dupilumab improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) and ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Rural women with COPD face rising mortality rates, while urban women and men see declines. A new study highlights the social ...

Dr. Christopher Stanley will serve as president of the new nonprofit subsidiary headquartered in Troy, which employs 150.

On Sept 17, 2024, tobacco giant Philip Morris International (PMI) announced that it was selling Vectura at an enormous loss. Vectura, a pharmaceutical company that specialises in inhaled medicines for ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Less frequent dosing could provide Eli Lilly’s Ebglyss room to rival Sanofi and Regeneron’s blockbuster Dupixent.